Cornea/External Disease News

NASHVILLE, Tenn. — A clinician shared his experience using Vevye in a post-cataract surgery patient with autoimmune disease in this Healio video at Optometry’s Meeting.

NASHVILLE, Tenn. — Alcon’s U.S. pharmaceutical division shared its focus on glaucoma and dry eye with attendees at Optometry’s Meeting.

NASHVILLE, Tenn. — BioTissue’s CAM360 AmnioGraft is showing early success in treating mild to moderate dry eye, according to a company executive here at Optometry’s Meeting.

NASHVILLE, Tenn. — Short-term noninvasive tear breakup time increased with use of Lumify eye drops in cohort of patients with and without dry eye disease, according to a poster presented at Optometry’s Meeting.

NASHVILLE, Tenn. — A preservative-free brimonidine tartrate ophthalmic solution was statistically noninferior to Bausch + Lomb’s Lumify, offering an alternative option for ocular redness relief, according to a poster at Optometry’s Meeting.

NASHVILLE, Tenn. — Patients with keratoconus may need a variety of contact lenses after surgery, making it critical for clinicians to have multiple options in their toolbox, according to a speaker at Optometry’s Meeting.

The FDA granted breakthrough therapy and regenerative medicine advanced therapy designations for AURN001 for the treatment of corneal edema secondary to corneal endothelial disease, according to a press release from Aurion Biotech.

In addition to accidental ocular injury associated with e-cigarettes, chronic users may experience reduced tear film quality and stability, potentially increasing the risk for dry eye disease, according to a systematic review.

Obstructive sleep apnea appears to increase the risk for ptosis repair failure and revision surgery, according to a study in Ophthalmic Plastic and Reconstructive Surgery.

KIAWAH ISLAND, S.C. — A study suggested that electrocardiogram screening should be performed in patients with sarcoidosis-associated uveitis because life-threatening cardiac involvement may be present even without symptoms.